Related Experiment Video
Updated: Mar 1, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant
Howard E Boudreau1, Wei Feng Ma1, Agnieszka Korzeniowska1
1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract:
Previously, we showed wild-type (WT) and mutant (mut) p53 differentially regulate reactive oxygen species (ROS) generation by NADPH oxidase-4 (NOX4): p53-WT suppresses TGFβ-induced NOX4, ROS and cell migration, whereas tumor-associated mut-p53 proteins enhance NOX4 expression and cell migration. Here, we extended our findings on the effects of p53 on NOX4 in several tumors and examined the basis of NOX4 transcriptional regulation by p53 and SMAD3. Statistical analysis of expression data from primary tumors available from The Cancer Genome Atlas (TCGA) detected correlations between mut-p53 and increased NOX4 expression. Furthermore, by altering p53 levels in cell culture models we showed several common tumor-associated mutant forms support TGFβ/SMAD3-dependent NOX4 expression. Deletion analysis revealed two critical SMAD3 binding elements (SBE) required for mut-p53-dependent NOX4 induction, whereas p53-WT caused dose-dependent suppression of NOX4 transcription. ChIP analysis revealed SMAD3 and p53-WT or mut-p53 associate with SBEs and p53 response elements in a TGFβ-dependent manner. Interestingly, the repressive effects of p53-WT on NOX4 were relieved by mutation of its transactivation domain or histone deacetylase (HDAC) inhibitor treatment. Overexpression of p300, a transcriptional co-regulator and histone acetyltransferase (HAT), enhanced p53-mediated NOX4 induction, whereas HAT-inactive p300 reduced NOX4 expression. Mut-p53 augmented TGFβ-stimulated histone acetylation within the NOX4 promoter. Finally, wound assays demonstrated NOX4 and p300 promote TGFβ/mut-p53-mediated cell migration. Our studies provide new insight into TGFβ/SMAD3 and mut-p53-mediated NOX4 induction involving epigenetic control of NOX4 in tumor cell migration, suggesting NOX4 is a potential therapeutic target to combat tumor progression and metastasis.
Insights
Mutant p53 proteins enhance NADPH oxidase-4 (NOX4) expression and tumor cell migration, while wild-type p53 suppresses it. This involves epigenetic regulation of NOX4, suggesting NOX4 as a therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Wild-type (WT) p53 suppresses reactive oxygen species (ROS) and cell migration, whereas mutant (mut) p53 enhances them.
- NADPH oxidase-4 (NOX4) is implicated in tumor progression and metastasis.
- Transforming growth factor-beta (TGFβ) signaling plays a role in cancer development.
Purpose of the Study:
- To investigate the role of p53 and SMAD3 in the transcriptional regulation of NOX4.
- To explore the epigenetic mechanisms underlying NOX4 induction by mutant p53.
- To identify NOX4 as a potential therapeutic target for cancer treatment.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) data for correlations between p53 mutations and NOX4 expression.
- Cell culture experiments to study the effects of p53 levels on NOX4 expression.
- Chromatin immunoprecipitation (ChIP) assays to examine protein-DNA interactions.
- Histone acetylation analysis of the NOX4 promoter.
- Wound healing assays to assess cell migration.
Main Results:
- Mutant p53 correlates with increased NOX4 expression in tumors.
- Mutant p53 supports TGFβ/SMAD3-dependent NOX4 expression via specific SMAD3 binding elements (SBEs).
- Wild-type p53 suppresses NOX4 transcription, an effect reversed by transactivation domain mutation or HDAC inhibitors.
- p300 (a histone acetyltransferase) enhances NOX4 induction, and mutant p53 augments TGFβ-stimulated histone acetylation in the NOX4 promoter.
- NOX4 and p300 promote TGFβ/mutant p53-mediated cell migration.
Conclusions:
- Mutant p53, SMAD3, and epigenetic modifications converge to induce NOX4 expression, promoting tumor cell migration.
- NOX4 is a key mediator in the TGFβ/mutant p53 signaling pathway.
- Targeting NOX4 may offer a therapeutic strategy against cancer progression and metastasis.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
TGF - β Signaling Pathway
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle

